Clover Health Investments...

NASDAQ: CLOV · Real-Time Price · USD
3.15
0.02 (0.64%)
At close: May 30, 2025, 3:59 PM
3.14
-0.16%
After-hours: May 30, 2025, 05:51 PM EDT

Clover Health Investments Statistics

Share Statistics

Clover Health Investments has 508.92M shares outstanding. The number of shares has increased by 2.91% in one year.

Shares Outstanding 508.92M
Shares Change (YoY) 2.91%
Shares Change (QoQ) 1.96%
Owned by Institutions (%) 18.94%
Shares Floating n/a
Failed to Deliver (FTD) Shares 2,970
FTD / Avg. Volume 0.05%

Short Selling Information

The latest short interest is 15.58M, so 3.06% of the outstanding shares have been sold short.

Short Interest 15.58M
Short % of Shares Out 3.06%
Short % of Float 3.84%
Short Ratio (days to cover) 2.31

Valuation Ratios

The PE ratio is -35.89 and the forward PE ratio is -156. Clover Health Investments's PEG ratio is 0.44.

PE Ratio -35.89
Forward PE -156
PS Ratio 1.13
Forward PS 0.5
PB Ratio 4.52
P/FCF Ratio 46.37
PEG Ratio 0.44
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Clover Health Investments.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.

Current Ratio 1.61
Quick Ratio 1.61
Debt / Equity 0
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $2,405,492.98
Profits Per Employee $-75,454.39
Employee Count 570
Asset Turnover 2.36
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 174.56% in the last 52 weeks. The beta is 2, so Clover Health Investments's price volatility has been higher than the market average.

Beta 2
52-Week Price Change 174.56%
50-Day Moving Average 3.51
200-Day Moving Average 3.56
Relative Strength Index (RSI) 37.83
Average Volume (20 Days) 6,082,177

Income Statement

In the last 12 months, Clover Health Investments had revenue of 1.37B and earned -43.01M in profits. Earnings per share was -0.08.

Revenue 1.37B
Gross Profit 364.8M
Operating Income -45.75M
Net Income -43.01M
EBITDA -44.94M
EBIT -46.27M
Earnings Per Share (EPS) -0.08
Full Income Statement

Balance Sheet

The company has 194.54M in cash and 0 in debt, giving a net cash position of 194.54M.

Cash & Cash Equivalents 194.54M
Total Debt n/a
Net Cash n/a
Retained Earnings -2.2B
Total Assets 583.72M
Working Capital 115.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.84M and capital expenditures -1.56M, giving a free cash flow of 33.29M.

Operating Cash Flow 34.84M
Capital Expenditures -1.56M
Free Cash Flow 33.29M
FCF Per Share 0.07
Full Cash Flow Statement

Margins

Gross margin is 26.61%, with operating and profit margins of -3.34% and -3.14%.

Gross Margin 26.61%
Operating Margin -3.34%
Pretax Margin -3.37%
Profit Margin -3.14%
EBITDA Margin -3.28%
EBIT Margin -3.34%
FCF Margin 2.43%

Dividends & Yields

CLOV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CLOV is $4.5, which is 43.8% higher than the current price. The consensus rating is "Buy".

Price Target $4.5
Price Target Difference 43.8%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score 1.22
Piotroski F-Score 2